Kajbaf, Mahmud <br/><br/>
A comparative study of the CYP450 inhibition potential of marketed drugs using two fluorescence based assay platforms routinely used in the pharmaceutical industry.  [electronic resource] 

 -  Drug metabolism letters  Jan 2011 
 - 30-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1874-0758 
<br/><br/><label>Standard No.: </label>10.2174/187231211794455262  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Automation<br/>Cell Line<br/>Cytochrome P-450 Enzyme Inhibitors<br/>Cytochrome P-450 Enzyme System--genetics<br/>Dose-Response Relationship, Drug<br/>Drug Discovery--methods<br/>Drug Interactions<br/>Enzyme Inhibitors--pharmacology<br/>Escherichia coli--enzymology<br/>Fluorescence<br/>High-Throughput Screening Assays--methods<br/>Humans<br/>Microsomes--drug effects<br/>Molecular Probes<br/>Recombinant Proteins--antagonists & inhibitors<br/>Reproducibility of Results<br/>Substrate Specificity<br/>Technology, Pharmaceutical--methods<br/>Transfection